trending Market Intelligence /marketintelligence/en/news-insights/trending/pd2ngmceeel0yflyeamuow2 content esgSubNav
In This List

Grifols to set up plasma collection centers in China

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Grifols to set up plasma collection centers in China

Grifols SA will collaborate with Chinese biotechnology company Boya Bio-pharmaceutical Group Co. Ltd. to build and manage plasma collection centers in the Asian country.

The collaboration will begin with an initial investment of €50 million.

Spain-based Grifols is a major world supplier of plasma-derived products.